<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

COVID-19 Weekly Brief

This weekly snapshot gives you a quick briefing on the state of COVID-19 therapy and vaccines development. As we head into June, nearly 1500 trials have been registered and over 100,000 patients have been recruited into said trials.

Here is what you need to know:

  • Although 1500 trials are registered only 55% of them are recruiting. An additional 6% have completed, which means about 40% are still waiting to commence recruitment. These last set of trials are largely based in the United States, China and India.
  • Nearly 28% of trials that are recruiting are EU trials and 20% are based in the United States.
  • The United States, China, Iran, Spain and France making up the top 5 countries in which trials are currently recruiting.
  • About 62% of trials currently recruiting have a Standard of Care arm. Another 12% are single-arm studies. The remainder are multiple dose studies, or multi-active intervention studies.

To learn more click here:


Access Tracker

To read the monthly overview for May click link below:




contact iconSubscribe back to top